Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial.

< BACK TO ARCHIVE


2020 Jun 17


Neurology


http://www.ncbi.nlm.nih.gov/pubmed/32554770?dopt=Abstract

Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial.

Authors

Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial.
Salter A, Kowalec K, Fitzgerald K, Cutter G, Marrie R A
Neurology. 2020 Jun 17.
PMID: 32554770.

Abstract

To determine whether comorbidity is associated with clinical (relapses, disability worsening) and MRI outcomes in multiple sclerosis (MS), we conducted a secondary analysis of the CombiRx clinical trial.
Read This Paper